BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 17, 2012
View Archived Issues
New potential analgesics disclosed by Novartis
Read More
GSK presents novel ITK/TSK inhibitors
Read More
Exelixis discovers new PI3Kdelta inhibitors
Read More
Novel inhibitors of neurotransmitter reuptake developed in Japan
Read More
Preclinical data support clinical testing of AVEO antibody
Read More
Addex discloses encouraging data on lead oral small molecule
Read More
Multitargeted antimitotic drug achieves tumor regression in vivo
Read More
Two new promising oncology programs presented
Read More
Regeneron Pharmaceuticals generates new anticancer antibody
Read More
Scientists describe analgesic effects of novel cannabinoid CB2 receptor agonists
Read More
First patient dosed in pivotal Arikace study
Read More
QRxPharma completes phase I trials of MoxDuo CR
Read More
New potential pancreatic cancer biomarker identified at H. Lee Moffitt Center
Read More
Vanda Pharmaceuticals acquires tachykinin NK1 receptor antagonist
Read More
Proteros and Eisai launch research collaboration
Read More
Merck & Co. gains worldwide rights to anticancer conjugate
Read More
UCB reports on phase III axial spondyloarthritis trial
Read More
Another milestone reached in phase IIa Cx-611 study
Read More
Novartis seeking approval in Japan of Glivec for new indication
Read More
Conformetrix enters first collaboration agreement
Read More
Dainippon Sumitomo Pharma seeks approval in Japan for Surepost in combination therapy
Read More
Eisai set to launch GABA(A) receptor agonist in Japan
Read More
Daiichi Sankyo launches Ranmark in Japan
Read More
Otsuka Pharmaceutical plans launch of new Abilify formulation
Read More
ThromboGenics resubmits BLA for ocriplasmin
Read More
Inspiration Biopharmaceuticals files for approval of rFIX product
Read More